Status:
ACTIVE_NOT_RECRUITING
Comprehensive Segmental Revision System
Lead Sponsor:
Zimmer Biomet
Conditions:
Degenerative Disease
Oncology
Eligibility:
All Genders
Brief Summary
Clinical Data evaluation to document the performance and clinical outcomes of the Comprehensive Segmental Revision System.
Detailed Description
The Purpose of this multi centre clinical data evaluation is to document the performance and clinical outcomes of the Comprehensive Segmental revision System. The data gathered will be collated and us...
Eligibility Criteria
Inclusion
- Non Inflammatory Degenerative joint disease, including osteoarthritis, and avascular necrosis
- Rheumatoid arthritis
- Revision where other devices or treatments have failed
- Correction of functional deformity
- Oncology applications including bone loss due to tumour resection
Exclusion
- Sepsis ( active)
- Infection ( active)
- Osteomyelitis (active)
Key Trial Info
Start Date :
April 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2035
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT03270982
Start Date
April 1 2016
End Date
December 1 2035
Last Update
December 23 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Nova Scotia Health Authority
Halifax, Nova Scotia, Canada, B3H-1796
2
Department of Orthopedic Surgery, Rigshospitalet University of Copenhagen
Copenhagen, Denmark
3
Royal Gwent Hospital
Newport, Wales, United Kingdom, NP20 2UB
4
Royal Liverpool University Hospital
Liverpool, United Kingdom